Johnson Johnson Ownership
| JNJ Stock | USD 162.99 1.26 0.77% |
Johnson |
Johnson Stock Ownership Analysis
About 74.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.12. Johnson Johnson recorded earning per share (EPS) of 5.75. The entity last dividend was issued on the 18th of February 2025. The firm had 2:1 split on the 13th of June 2001. Johnson Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company was founded in 1886 and is based in New Brunswick, New Jersey. Johnson Johnson operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 141700 people. To learn more about Johnson Johnson call Alex Gorsky at 732 524 0400 or check out https://www.jnj.com.Johnson Johnson Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Johnson Johnson insiders, such as employees or executives, is commonly permitted as long as it does not rely on Johnson Johnson's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Johnson Johnson insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Kristen Mulholland over a month ago Disposition of 1007 shares by Kristen Mulholland of Johnson Johnson subject to Rule 16b-3 | ||
Mulholland Kristen over a month ago Insider Trading | ||
Mulholland Kristen over a month ago Insider Trading | ||
Mulholland Kristen over a month ago Insider Trading | ||
Mulholland Kristen over a month ago Insider Trading | ||
Mulholland Kristen over a month ago Insider Trading | ||
Mulholland Kristen over a month ago Insider Trading | ||
Mulholland Kristen over a month ago Insider Trading | ||
Mulholland Kristen over a month ago Insider Trading | ||
Mulholland Kristen over two months ago Insider Trading | ||
Ronald Williams over a year ago Acquisition by Ronald Williams of 1428 shares of Johnson Johnson subject to Rule 16b-3 |
Johnson Johnson's latest congressional trading
Congressional trading in companies like Johnson Johnson, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Johnson Johnson by those in governmental positions are based on the same information available to the general public.
| 2025-03-10 | Representative Jefferson Shreve | Acquired $15K to $50K | Verify | ||
| 2025-02-12 | Representative Gil Cisneros | Acquired Under $15K | Verify | ||
| 2025-02-11 | Representative Josh Gottheimer | Acquired Under $15K | Verify | ||
| 2025-01-28 | Representative Marjorie Taylor Greene | Acquired Under $15K | Verify | ||
| 2025-01-16 | Representative Kevin Hern | Acquired $100K to $250K | Verify | ||
| 2025-01-15 | Representative Josh Gottheimer | Acquired Under $15K | Verify | ||
| 2025-01-09 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2025-01-07 | Representative Virginia Foxx | Acquired Under $15K | Verify | ||
| 2024-12-30 | Representative Marjorie Taylor Greene | Acquired Under $15K | Verify | ||
| 2024-12-09 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
| 2024-12-06 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
| 2024-12-05 | Representative Josh Gottheimer | Acquired Under $15K | Verify | ||
| 2024-11-28 | Representative Marjorie Taylor Greene | Acquired Under $15K | Verify | ||
| 2024-11-14 | Senator Tommy Tuberville | Acquired $15K to $50K | Verify | ||
| 2024-10-11 | Representative Lloyd Doggett | Acquired Under $15K | Verify | ||
| 2024-09-06 | Representative John James | Acquired Under $15K | Verify | ||
| 2024-08-20 | Senator Sheldon Whitehouse | Acquired $15K to $50K | Verify | ||
| 2024-08-16 | Representative Kathy Manning | Acquired Under $15K | Verify | ||
| 2024-08-08 | Representative Richard W Allen | Acquired $15K to $50K | Verify | ||
| 2024-01-16 | Senator Jerry Moran | Acquired Under $15K | Verify | ||
| 2023-11-15 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2023-10-20 | Senator Pete Ricketts | Acquired $100K to $250K | Verify | ||
| 2023-10-02 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
| 2023-09-22 | Senator Dan Sullivan | Acquired Under $15K | Verify | ||
| 2023-09-17 | Senator Dan Sullivan | Acquired Under $15K | Verify | ||
| 2022-11-12 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2022-02-03 | Senator Thomas R Carper | Acquired Under $15K | Verify |
Johnson Johnson Outstanding Bonds
Johnson Johnson issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Johnson Johnson uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Johnson bonds can be classified according to their maturity, which is the date when Johnson Johnson has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| JOHNSON JOHNSON 695 Corp BondUS478160AJ37 | View | |
| JOHNSON JOHNSON 495 Corp BondUS478160AL82 | View | |
| JOHNSON JOHNSON 595 Corp BondUS478160AN49 | View | |
| JOHNSON JOHNSON 585 Corp BondUS478160AT19 | View | |
| JOHNSON JOHNSON 45 Corp BondUS478160AV64 | View | |
| JOHNSON JOHNSON 485 Corp BondUS478160BA19 | View | |
| JOHNSON JOHNSON 29 Corp BondUS478160CK81 | View | |
| JOHNSON JOHNSON 35 Corp BondUS478160CM48 | View |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Johnson Stock please use our How to buy in Johnson Stock guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Johnson Johnson. If investors know Johnson will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Johnson Johnson listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Johnson Johnson is measured differently than its book value, which is the value of Johnson that is recorded on the company's balance sheet. Investors also form their own opinion of Johnson Johnson's value that differs from its market value or its book value, called intrinsic value, which is Johnson Johnson's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Johnson Johnson's market value can be influenced by many factors that don't directly affect Johnson Johnson's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Johnson Johnson's value and its price as these two are different measures arrived at by different means. Investors typically determine if Johnson Johnson is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Johnson Johnson's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.